JE
GILD icon

JMAC Enterprises’s Gilead Sciences GILD Stock Holding History

JMAC Enterprises’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$657K Buy
5,200
+2,400
+86% +$316K 0.11% 86
2026
Q1 		$390K Sell
2,800
-500
-15% -$70K 0.07% 101
2025
Q4 		$405K Buy
+3,300
New +$401K 0.08% 98
2022
Q4 		– Sell
-10,050
Closed -$620K – 178
2022
Q3 		$620K Buy
10,050
+1,000
+11% +$63.1K 0.17% 111
2022
Q2 		$559K Buy
9,050
+200
+2% +$12.4K 0.14% 119
2022
Q1 		$526K Hold
8,850
– – 0.12% 123
2021
Q4 		$565K Buy
+8,850
New +$610K 0.13% 118

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JMAC Enterprises's GILD Position: Q2 2026 in Review

JMAC Enterprises increased its Gilead Sciences (GILD) stake by 86% in Q2 2026, buying an estimated $316K and bringing the position to 5,200 shares worth $657K. The position accounts for 0.11% of the portfolio, ranked #86.

JMAC Enterprises first reported a position in GILD in Q4 2021 and has held it in 7 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • JMAC Enterprises held 5,200 shares of Gilead Sciences worth $657K as of Q2 2026.
  • JMAC Enterprises bought 2,400 Gilead Sciences shares in Q2 2026, an estimated $316K.
  • Gilead Sciences made up 0.11% of JMAC Enterprises's portfolio in Q2 2026, its #86 holding.
  • JMAC Enterprises first reported a position in Gilead Sciences in Q4 2021 and has held it in 7 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on JMAC Enterprises's 13F filing for Q2 2026, filed 28 Jul 2026.